Please login to the form below

Not currently logged in
Email:
Password:

90TEN boosts PR division with new hires

Appoints Willoughby Badger, Deepa Patel and Anna Reidinger

90TEN Willoughby Badger Deepa Patel Anna Reidinger 
Pictured from left: Anna Reidinger, Deepa Patel and Willoughby Badger

90TEN has made a series of new appointments, adding Willoughby Badger, Deepa Patel and Anna Reidinger to its PR division.

Badger joins the London-based PR and medical education consultancy from inVentiv Health's Biosector 2 agency, where he was responsible for its global advocacy programmes.

Prior to that he began his career on the Chandler Chicco Companies graduate scheme and was a finalist for the 2013 Communiqué Young Achiever in Healthcare Communications award.

Patel moves to 90TEN following three years at Tonic Life Communications, where she worked on international accounts spanning oncology, neurology and medical devices.

Before joining Tonic she served as a clinical trials data manager for Coventry and Warwickshire NHS Trust.

Finally, Reidinger is a recent biomedical science graduate and previously conducted research into HIV at the Chelsea and Westminster Hospital in London.

Peter Impey, 90TEN's director of PR, said: “During 2015 and the early part of 2016, we have enjoyed rapid growth with a combination of organic growth and new business wins.

“We are delighted to have strengthened our team with the talent of Will, Deepa and Anna who will help us to consolidate our success and develop the company further into the future.”

Article by
Dominic Tyer

13th May 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics